ABI
COV

Adamant Biomedical Investments’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Adamant Biomedical Investments’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.02M Sell
10,000
-50,000
-83% -$4.8M 0.24% 81
2014
Q3 		$5.19M Buy
+60,000
New +$5.31M 1.3% 26

Other funds holding COV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Adamant Biomedical Investments's COV Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its COVIDIEN PLC COM SHS NEW (IRELAND) (COV) stake by 83% in Q4 2014, selling an estimated $4.8M and leaving 10,000 shares worth $1.02M. The position accounts for 0.24% of the portfolio, ranked #81.

Adamant Biomedical Investments first reported a position in COV in Q3 2014 and has held it in 2 quarters since. The position peaked at $5.19M in Q3 2014. 758 funds tracked by Wall St. Rank hold COV as of Q4 2014.

  • Adamant Biomedical Investments held 10,000 shares of COVIDIEN PLC COM SHS NEW (IRELAND) worth $1.02M as of Q4 2014.
  • Adamant Biomedical Investments sold 50,000 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q4 2014, an estimated $4.8M.
  • COVIDIEN PLC COM SHS NEW (IRELAND) made up 0.24% of Adamant Biomedical Investments's portfolio in Q4 2014, its #81 holding.
  • Adamant Biomedical Investments first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $5.19M in Q3 2014.
  • 758 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.